Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$16.95 - $27.04 $779 - $1,243
46 Added 8.86%
565 $15,000
Q4 2023

Feb 08, 2024

BUY
$6.29 - $15.72 $2,905 - $7,262
462 Added 810.53%
519 $6,000
Q3 2023

Nov 14, 2023

SELL
$14.99 - $32.65 $239 - $522
-16 Reduced 21.92%
57 $0
Q2 2023

Aug 09, 2023

BUY
$29.76 - $46.14 $1,726 - $2,676
58 Added 386.67%
73 $2,000
Q4 2022

Feb 10, 2023

BUY
$40.54 - $56.2 $81 - $112
2 Added 15.38%
15 $0
Q3 2022

Nov 10, 2022

BUY
$36.98 - $49.2 $443 - $590
12 Added 1200.0%
13 $1,000
Q2 2022

Aug 09, 2022

SELL
$28.03 - $45.8 $336 - $549
-12 Reduced 92.31%
1 $0
Q1 2022

May 06, 2022

BUY
$29.24 - $44.06 $380 - $572
13 New
13 $1,000
Q4 2021

Feb 01, 2022

SELL
$39.32 - $61.61 $432 - $677
-11 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$44.0 - $65.8 $484 - $723
11 New
11 $1,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.